Allen Yang, MD, PhD, CMO of Summit Therapeutics discusses the clinical development strategy for Ivonescimab, the difference between Western and Chinese innovation and navigating international regulatory interactions.
Allen Yang, MD, PhD, CMO of Summit Therapeutics discusses the clinical development strategy for Ivonescimab, the difference between Western and Chinese innovation and navigating international regulatory interactions.